糖尿病病人的不断增长带来胰岛素需求量的不断上升。 来自有关方面的信息显示:我国现有四千万左右的糖尿病人,其中数百万人需要长期使用胰岛素。世界生物制药巨头都把胰岛素作为企业发展的战略方向之一,而且把目光瞄准亚洲。全世界糖尿病患者最多的三个国家有两个在亚洲,即中国和印度。 The growing demand for diabetes has led to an increase in the demand for insulin. Information from the relevant authorities shows that there are about 40 million people with diabetes in our country, and millions of people need long-term use of insulin. The world’s biopharmaceutical giants regard insulin as one of the strategic directions for the development of their enterprises and they are targeting Asia. Two of the three countries with the most diabetes in the world are in Asia, namely China and India.